Nafazatrom: in-vitro assessment of radiation and drug activity against animal and human cell lines Judith Stitt HaasCharles D. HaasGregg W. Kyle Special Symposium on Nafazatrom Pages: 3 - 6
Nafazatrom: clonogenic in-vitro assessment of activity against human malignancies Charles D. HaasGregg W. KyleMichael F. Schaldenbrand Special Symposium on Nafazatrom Pages: 7 - 11
Phase I and pharmacologic evaluation of nafazatrom in patients with cancer Charles D. HaasLaurence H. BakerLlewelyn J. Evans Jr Special Symposium on Nafazatrom Pages: 13 - 17
Effects of diflubenzuron on growth of malignant melanoma and skin carcinoma tumors in mice Vernon K. JenkinsRichard T. MayerRobert R. Perry Preclinical Studies Pages: 19 - 27
Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro Bridget T. HillAngela S. BellamyR. D. H. Whelan Preclinical Studies Pages: 29 - 33
Antitumor cell and antimetabolic effects of 5-ethyl-2′-deoxyuridine and 5′-substituted 5-ethyl-2′-deoxyuridine derivatives Jan BalzariniErik De ClercqAlfred Buchele Preclinical Studies Pages: 35 - 47
Antitumor activity of vinzolidine in the human tumor clonogenic assay and comparison with vinblastine Bonnie J. TakasugiSydney E. SalmonRosa M. Liu Preclinical Studies Pages: 49 - 53
Activity of Carbetimer in a human tumor cloning system Daniel L. KisnerPersis MehtaDaniel D. Von Hoff Preclinical Studies Pages: 55 - 58
The human tumor colony-forming chemosensitivity assay: A biological and clinical review Edward C. BradleyBrian F. IssellRichard Hellman Preclinical Studies Pages: 59 - 70
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer William A. Knight IIIRobert M. O'BryanJohn J. Costanzi Clinical Trials Pages: 71 - 73
Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomas Thomas P. MillerStephen E. JonesCindy Mackel Clinical Trials Pages: 75 - 77
Tiazofurin: A new antitumor agent Peter J. O'DwyerD. Dale ShoemakerRuth D. Davis Clinical Trials Pages: 79 - 84
Fourth NCI - EORTC Symposium on New Drugs in Cancer Therapy Brussels, Belgium December 14–17, 1983 Abstracts Pages: 85 - 128